Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,294.9
0.0 (0.00%)

 

  • STI Straits Times Index
    3,294.9
    0.0 (0.00%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,527.1
    -0.7 (-0.05%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,965.5
    13.2 (0.05%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,522.6
    -32.5 (-0.91%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 805.0M
  • Value: 1,097.8M
  • Rise: 135
  • Fall: 158
  • Unch: 474

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.086+0.003
DISA0.009+0.001
ThaiBev0.660+0.005
The Place Hldg0.074+0.016
Geo Energy Res0.355+0.025
Sembcorp Marine0.083-
Arion Ent0.011+0.001
Singtel2.480+0.010
Oceanus0.029+0.001
Genting Sing0.775-0.005

World Indices

World Indices
Name Last Change
Nasdaq 13,768.9 -385.1
HSI 24,965.5 +13.2
HSCEI 8,787.3 +25.7
Jakarta 6,726.4 +99.5
Nikkei 225 27,522.3 -250.7
SSE Comp 3,522.6 -32.5
Shanghai A 3,691.5 -34.1
Shanghai B 286.2 -0.8
KOSPI 2,834.3 -28.4

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

XOMA CORP XOMA CORPORATION
Updated on 21 Jan 2022 (End of trading day)
Last (USD): 21.340 Change: +0.450 High: 21.630 Remarks: -
Change (%): +2.15 Low: 20.660
Open 20.660 Yesterday's Close 20.89
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 44,359 Cumulative Value

Company Background

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Click to show Stock Prices chart

Key Statistics

EPS (USD) a 0.77737 Trailing EPS (USD) b -0.14870 NAV (USD) c 9.8606
PE a 27.452 Trailing PE d - Price / NAV c 2.1642
Dividend Yield (%) e - Cash In Hand (USD) f 6.3808 Issued & Paid-up Shares g 11,311,200
Piotroski F Score 7 Market Cap (M) 241.381 Free Float (%) 94.6
Return on Equity (ROE) (%) h n.m. Revenue Growth (%) TTM i 1,237.943
Net Earnings Growth (%) j 87.713 Net Debt/Equity k Net Cash
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 06 Aug 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.980
-4.39 %
10 Days --0.960
-4.30 %
20 Days --1.980
-8.49 %
Medium Term Return 3 Months --3.370
-13.64 %
6 Months --12.060
-36.11 %
1 Year --17.970
-45.71 %
Long Term Return 2 Years --1.880
-8.10 %
3 Years -+8.690
+68.70 %
5 Years -+16.940
+385.00 %
Annualised Return Annualised --
+37.14 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference XOMA CORP NASDAQ 241.381 27.452 - 2.1642 -
Industry Pharmaceuticals: Major NASDAQ 1,985.769 79.460 91.614 2.6001 0.029
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 183,139.080 57.302 124.500 4.6080 1.964
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 129,489.629 9.224 18.699 1.7267 2.642
Local Peer ROYALTY PHARMA PLC NASDAQ 23,764.790 24.373 30.358 4.1023 0.490
Local Peer VIATRIS INC NASDAQ 17,572.437 - - 0.8312 -
Local Peer REPLIGEN CORP NASDAQ 10,162.579 169.585 85.487 5.9248 -
Local Peer EVOTEC SE SPON ADS EACH REP 0.50 ORD SHS NASDAQ 6,998.939 981.791 23.759 6.0836 -
Local Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 6,089.616 - - 5.2885 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 5,992.504 - - 26.5309 -
Local Peer HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS NASDAQ 4,998.712 - - 5.0758 -
Local Peer CEREVEL THERAPEUTICS HLDGS INC NASDAQ 3,723.598 - - 5.9191 -
Local Peer CUREVAC NV NASDAQ 3,499.307 - - - -
Local Peer APELLIS PHARMACEUTICALS INC NASDAQ 3,405.770 - - -59.4069 -
Other Local Peers KARUNA THERAPEUTICS INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), OPKO HEALTH INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), EQRX INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), ERASCA INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), AMYLYX PHARMACEUTICALS INC (NASDAQ), PROCAPS GROUP S.A. (NASDAQ), QUANTERIX CORPORATION (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), GH RESEARCH PLC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), GOSSAMER BIO INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), ICOSAVAX INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), CINCOR PHARMA INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), PETIQ INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), PHARVARIS NV (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), KRONOS BIO INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), 2SEVENTY BIO INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), VERU INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), ALLAKOS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), GENERATION BIO CO (NASDAQ), XILIO THERAPEUTICS INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), GRITSTONE BIO INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), LANDEC CORP (NASDAQ), AC IMMUNE SA (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), PYXIS ONCOLOGY INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), ANNEXON INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ),